查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601020

局部麻醉劑市場：按藥物類型、類型、給藥方法、分銷管道、最終用途分類 - 全球預測 2025-2030

Local Anesthesia Drugs Market by Drug Type (Bupivacaine, Chloroprocaine, Lidocaine), Type (Over-the-Counter, Prescription), Mode of Administration, Distribution Channel, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年局部麻醉劑市值為26.5億美元，預計2024年將達28億美元，複合年成長率為5.47%，預計到2030年將達到38.6億美元。

局部麻醉劑對於麻醉身體的某些部位以防止手術、牙科手術和其他醫療干預期間的疼痛非常重要。這些藥物會阻斷神經傳導並導致周圍感覺喪失，但不會影響意識。局部麻醉在減少患者不適、促進小型手術、改善門診病人手術並最終促進更有效的醫療服務方面的作用強調了局部麻醉的必要性。應用範圍廣泛，包括牙科、眼科、美容外科和整形外科，最終用戶範圍從醫院和診所到門診手術中心和私人醫生。

主要市場統計
基準年[2023] 26.5億美元
預測年份 [2024] 28億美元
預測年份 [2030] 38.6億美元
複合年成長率（%） 5.47%

該市場的推動因素是慢性病增加和人口老化導致手術數量增加，需要低風險且有效的疼痛管理解決方案。技術進步，例如長效局部麻醉劑的開發，為滿足對高效和長效鎮痛不斷成長的需求提供了潛在的機會。此外，開發減少全身副作用的局部藥物輸送系統的機會正在迅速增加，並引起了極大的關注。

然而，該市場面臨嚴格的監管要求的挑戰，這些要求可能會延遲產品核可，以及某些患者出現副作用或過敏反應的風險，這可能會限制廣泛採用。此外，COVID-19 大流行擾亂了供應鏈，並使市場動態更加複雜。生物分解性麻醉劑和非注射給藥方法等領域的創新可能會推動未來的成長。企業應投資研發副作用較少的藥物，並與醫療機構合作，更了解其實際效果。市場競爭仍然激烈且充滿活力，需要策略定價、遵守監管標準並保持適應性以實現永續成長。

市場動態：揭示快速發展的局部麻醉劑市場的關鍵市場洞察

供需的動態交互作用正在改變局部麻醉劑市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 隨著全球手術數量的增加，用於治療術後疼痛的局部麻醉劑的使用量增加
    • 擴大局部麻醉劑並提高核准率
  • 市場限制因素
    • 與局部麻醉劑產品召回相關的潛在風險
  • 市場機會
    • 整合奈米藥物輸送系統以實現有效的局部麻醉劑
    • 投資合成和非鴉片類局部麻醉劑的研發
  • 市場挑戰
    • 局部麻醉劑的副作用

波特五力：駕馭局部麻醉劑市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解局部麻醉劑市場的外部影響

外部宏觀環境因素局部麻醉劑市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解局部麻醉劑市場競爭狀況

對局部麻醉劑市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣局部麻醉劑市場供應商的績效評估

FPNV定位矩陣是評估局部麻醉劑市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃局部麻醉劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，局部麻醉劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的手術數量不斷增加，用於治療術後疼痛的局部麻醉劑的使用也在增加。
      • 擴大局部麻醉劑範圍並提高核准率
    • 抑制因素
      • 與局部麻醉劑產品召回相關的潛在風險
    • 機會
      • 整合奈米藥物輸送系統以實現有效的局部麻醉劑
      • 投資合成和非鴉片類局部麻醉劑的研發
    • 任務
      • 局部麻醉劑的副作用
  • 市場區隔分析
    • 藥物類型：提高Lidocaine功效、快速起效和應用多功能性的進展
    • 類型：使用處方箋局部麻醉劑進行中度和高度侵入性手術
    • 給藥方式：注射麻醉劑對精準應用的新青睞
    • 分銷管道：醫院藥房在確保醫院內即時可靠地獲得局部麻醉劑發揮關鍵作用。
    • 最終用途：在醫院的各種外科手術中廣泛使用局部麻醉劑
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依藥物類型分類的局部麻醉劑市場

  • Bupivacaine
  • Chloroprocaine
  • Lidocaine
  • Mepivacaine/卡波卡因
  • Prilocaine
  • Ropivacaine

第7章局部麻醉劑市場：依類型

  • 在商店
  • 處方箋

第8章局部麻醉劑市場按管理方式

  • 可注射的
  • 表面麻醉

第9章局部麻醉劑市場：依通路分類

  • 藥局/藥房
  • 醫院藥房
  • 網路零售業

第 10 章局部麻醉劑市場：依最終用途分類

  • 門診手術中心
  • 牙醫診所
  • 醫院
  • 專科診所

第11章美洲局部麻醉劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太局部麻醉劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲局部麻醉劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 百特國際透過新型注射藥物擴大美國藥物組合
    • ZYNRELEF 的廣泛應用增強了各種手術過程中的術後疼痛管理
    • Heron Therapeutics 與 CrossLink Life Sciences 結成策略聯盟，加強 ZYNRELEF 的分銷
    • Scilex控股公司旗艦產品ZTlido（Lidocaine局部系統）獲得新專利
    • FDA核准Pasira 的 EXPAREL 的新申請，擴大非鴉片類疼痛治療
    • 3M 將其牙科局部麻醉產品組合策略出售給 Pierrel SpA
    • 費森尤斯·卡比 (Fresenius Kabi) 宣布推出支持 RFID 的羅庫溴銨注射液
    • Syntetica SA 擴大在美國的業務，在國內短缺的情況下推出鹽酸Lidocaine注射液
    • 政府與 Kautron 研究所合作，在藻類局部麻醉劑生產上取得突破
  • 戰略分析和建議
    • 阿斯彭醫藥控股有限公司
    • 百特國際有限公司
    • 帕西拉生物科技有限公司
    • Teva製藥有限公司
    • 愛爾康有限公司

公司名單

  • AdvaCare Pharma
  • Alcon Inc.
  • Anesiva, Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • B. Braun SE
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Dentsply Sirona Inc.
  • Eisai Co., Ltd.
  • Endo International PLC
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Heron Therapeutics, Inc.
  • Hikma Pharmaceuticals PLC
  • ICPA Health Products Limited
  • Mahendra Chemicals
  • Merck KGaA
  • Niksan Pharmaceutical
  • Novartis AG
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Pierrel SpA
  • Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd.
  • Septodont Holding
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Wellona Pharma
Product Code: MRR-742BD5180AE5

The Local Anesthesia Drugs Market was valued at USD 2.65 billion in 2023, expected to reach USD 2.80 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 3.86 billion by 2030.

Local anesthesia drugs are crucial in numbing specific areas of the body to prevent pain during surgical procedures, dental operations, and other medical interventions. These drugs block nerve conduction, leading to a loss of sensation in peripheral areas without affecting consciousness. The necessity of local anesthesia is underscored by its role in reducing patient discomfort, facilitating minor surgeries, and enhancing outpatient procedures, ultimately contributing to more efficient healthcare delivery. Its application spans across multiple domains including dentistry, ophthalmology, cosmetic surgery, and orthopedic processes, while end-users range from hospitals and clinics to ambulatory surgical centers and individual practitioners.

KEY MARKET STATISTICS
Base Year [2023] USD 2.65 billion
Estimated Year [2024] USD 2.80 billion
Forecast Year [2030] USD 3.86 billion
CAGR (%) 5.47%

The market is primarily driven by the increasing prevalence of surgeries due to rising chronic diseases and the growing elderly population, which necessitates low-risk, effective pain management solutions. Technological advancements, such as the development of long-acting local anesthetics, offer potential opportunities to cater to the growing demand for efficient and extended pain relief. Additionally, there's a burgeoning opportunity in developing localized drug delivery systems that reduce systemic side effects, thereby attracting significant attention.

However, the market faces challenges due to stringent regulatory requirements that can delay product approvals and the risk of side effects and allergic reactions in some patients, which can limit wider adoption. Moreover, the COVID-19 pandemic has disrupted supply chains, further complicating market dynamics. Innovating in areas such as biodegradable anesthetics and non-injection delivery methods may drive future growth. Companies should invest in R&D for drugs with fewer side effects and collaborate with medical institutions to better understand real-world efficacy. The market remains competitive and dynamic, requiring players to remain adaptive, ensuring strategic pricing and compliance with regulatory standards to capture sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Local Anesthesia Drugs Market

The Local Anesthesia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
    • Increase in expansion and approval rate of local anesthesia drugs
  • Market Restraints
    • Potential risk associated with the product recall of local anesthetic drugs
  • Market Opportunities
    • Integration of nano-based drug delivery systems for effective local anesthetics
    • Investment in R&D for synthetic and non-opioid local anesthetics
  • Market Challenges
    • Side effects of local anesthetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Local Anesthesia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Local Anesthesia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Local Anesthesia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Local Anesthesia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Local Anesthesia Drugs Market

A detailed market share analysis in the Local Anesthesia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Local Anesthesia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Local Anesthesia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Local Anesthesia Drugs Market

A strategic analysis of the Local Anesthesia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Local Anesthesia Drugs Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Alcon Inc., Anesiva, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun SE, Baxter International, Inc., Boehringer Ingelheim International GmbH, Dentsply Sirona Inc., Eisai Co., Ltd., Endo International PLC, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Heron Therapeutics, Inc., Hikma Pharmaceuticals PLC, ICPA Health Products Limited, Mahendra Chemicals, Merck KGaA, Niksan Pharmaceutical, Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Pierrel S.p.A., Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd., Septodont Holding, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Wellona Pharma.

Market Segmentation & Coverage

This research report categorizes the Local Anesthesia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Bupivacaine, Chloroprocaine, Lidocaine, Mepivacaine/ Carbocaine, Prilocaine, and Ropivacaine.
  • Based on Type, market is studied across Over-the-Counter and Prescription.
  • Based on Mode of Administration, market is studied across Injectable and Surface Anesthetic.
  • Based on Distribution Channel, market is studied across Drug Stores/Pharmacies, Hospitals Pharmacies, and Online Retailing.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers, Dental Clinics, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of local anesthetic for post-operative pain with rising surgeries across the globe
      • 5.1.1.2. Increase in expansion and approval rate of local anesthesia drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk associated with the product recall of local anesthetic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of nano-based drug delivery systems for effective local anesthetics
      • 5.1.3.2. Investment in R&D for synthetic and non-opioid local anesthetics
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects of local anesthetic drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Advancements to improve the effectiveness, rapid onset, and versatility in the application of lidocaine
    • 5.2.2. Type: Usage of prescription local anesthesia drugs for moderately and highly invasive surgeries
    • 5.2.3. Mode of Administration: Emerging preference for injectable anesthetics in precise applications
    • 5.2.4. Distribution Channel: Critical role played by hospital pharmacies for ensuring immediate and reliable access to local anesthesia drugs in hospital settings
    • 5.2.5. End-Use: Extensive utilization of local anesthesia drugs in hospital settings for diverse surgical operations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Local Anesthesia Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Bupivacaine
  • 6.3. Chloroprocaine
  • 6.4. Lidocaine
  • 6.5. Mepivacaine/ Carbocaine
  • 6.6. Prilocaine
  • 6.7. Ropivacaine

7. Local Anesthesia Drugs Market, by Type

  • 7.1. Introduction
  • 7.2. Over-the-Counter
  • 7.3. Prescription

8. Local Anesthesia Drugs Market, by Mode of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Surface Anesthetic

9. Local Anesthesia Drugs Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Drug Stores/Pharmacies
  • 9.3. Hospitals Pharmacies
  • 9.4. Online Retailing

10. Local Anesthesia Drugs Market, by End-Use

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Dental Clinics
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Americas Local Anesthesia Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Local Anesthesia Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Local Anesthesia Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Baxter International Inc. Expands the U.S. Pharmaceuticals Portfolio with New Injectable Products
    • 14.3.2. Broadened Applications of ZYNRELEF Enhance Postoperative Pain Management in Diverse Surgical Procedures
    • 14.3.3. Strategic Alliance between Heron Therapeutics and CrossLink Life Sciences to Enhance Distribution of ZYNRELEF
    • 14.3.4. New Patent Issuence for Scilex Holding Company for Its Lead Commercial Product ZTlido (lidocaine topical system)
    • 14.3.5. FDA Approves New Applications for Pacira's EXPAREL Expanding Non-Opioid Pain Management
    • 14.3.6. Strategic Divestiture of Dental Local Anesthetic Portfolio by 3M to Pierrel S.p.A.
    • 14.3.7. Fresenius Kabi Introduces RFID-Enabled Rocuronium Bromide Injection
    • 14.3.8. Sintetica S.A. Expands U.S. Presence with Launch of Lidocaine Hydrochloride Injection Amid National Shortage
    • 14.3.9. Breakthrough in Algae-Based Local Anaesthetic Production through Government-Cawthron Institute Partnership
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Aspen Pharmacare Holdings Limited
    • 14.4.2. Baxter International, Inc.
    • 14.4.3. Pacira BioSciences, Inc.
    • 14.4.4. Teva Pharmaceutical Industries Ltd.
    • 14.4.5. Alcon Inc.

Companies Mentioned

  • 1. AdvaCare Pharma
  • 2. Alcon Inc.
  • 3. Anesiva, Inc.
  • 4. Aspen Pharmacare Holdings Limited
  • 5. AstraZeneca PLC
  • 6. B. Braun SE
  • 7. Baxter International, Inc.
  • 8. Boehringer Ingelheim International GmbH
  • 9. Dentsply Sirona Inc.
  • 10. Eisai Co., Ltd.
  • 11. Endo International PLC
  • 12. F. Hoffmann-La Roche Ltd.
  • 13. Fresenius SE & Co. KGaA
  • 14. Heron Therapeutics, Inc.
  • 15. Hikma Pharmaceuticals PLC
  • 16. ICPA Health Products Limited
  • 17. Mahendra Chemicals
  • 18. Merck KGaA
  • 19. Niksan Pharmaceutical
  • 20. Novartis AG
  • 21. Pacira BioSciences, Inc.
  • 22. Pfizer Inc.
  • 23. Pierrel S.p.A.
  • 24. Sagent Pharmaceuticals by Nichi-Iko Pharmaceutical Co., Ltd.
  • 25. Septodont Holding
  • 26. Teva Pharmaceutical Industries Ltd.
  • 27. Viatris Inc.
  • 28. Wellona Pharma

LIST OF FIGURES

  • FIGURE 1. LOCAL ANESTHESIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. LOCAL ANESTHESIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LOCAL ANESTHESIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LOCAL ANESTHESIA DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHLOROPROCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE/ CARBOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURFACE ANESTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG STORES/PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE RETAILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023